home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410o.zip
/
M94A2819.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
2KB
|
35 lines
Document 2819
DOCN M94A2819
TI CD4 cell count in HIV-infected patients treated with oral IFN
alpha--preliminary report.
DT 9412
AU Smiatacz T; Dzierbicki A; Trocha H; Zielinska W; DPT, Gdansk School of
Medicine, Poland.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):218 (abstract no. PB0303). Unique
Identifier : AIDSLINE ICA10/94369756
AB OBJECTIVE: Evaluation of the influence of oral IFN (interferon) alpha
monotherapy of HIV-infected patients on the CD4 and CD8 cell count in
peripheral blood. METHODS: We studied 22 HIV-infected patients with
initial CD4 cell count less than 500 per cu mm during a period of 90
days. 11 of them received oral IFN alpha, 100u daily. 3 of them were
treated with AZT (zidovudine), 600-1200 mg per day. The remaining 8
patients did not receive any treatment because of lack of compliance
(active drug users). CD4 and CD8 cell count were determined using
fluorochrome labeled monoclonal antibodies (Becton-Dickinson) and
FACSort flow cytometer. TABULAR DATA, SEE ABSTRACT VOLUME. CONCLUSIONS:
After 90 days of treatment there was no significant difference in CD4
and CD8 cell count alteration between these groups of patients. However
an astounding improvement in general condition of the patients receiving
oral IFN alpha was observed. A follow-up study is essential to evaluate
the relevance of the results obtained.
DE Biological Response Modifiers/*PHARMACOLOGY/THERAPEUTIC USE Combined
Modality Therapy CD4-CD8 Ratio/DRUG EFFECTS Human HIV
Infections/BLOOD/DRUG THERAPY/*THERAPY
Interferon-alpha/*PHARMACOLOGY/THERAPEUTIC USE Leukocyte Count/*DRUG
EFFECTS T-Lymphocytes, Suppressor-Effector Treatment Outcome *T4
Lymphocytes Zidovudine/THERAPEUTIC USE MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).